Literature DB >> 21654715

Multiple sclerosis: HLA-DRB1 genotypes linked to the risk of developing neutralizing antibodies to recombinant IFN-β during therapy.

Katy Malpass.   

Abstract

Entities:  

Year:  2011        PMID： 21654715     DOI： 10.1038/nrneurol.2011.70

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Influence of the HLA-DRB1 genotype on antibody development to interferon beta in multiple sclerosis.

Authors:  Dorothea Buck; Sabine Cepok; Steve Hoffmann; Verena Grummel; Angela Jochim; Achim Berthele; Hans-Peter Hartung; Ralf Wassmuth; Bernhard Hemmer
Journal:  Arch Neurol       Date:  2011-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.